Article
SOAT1: A Suitable Target for Therapy in High-Grade Astrocytic Glioma?
International journal of molecular sciences - 28 Mar 2022
Löhr Mario, Härtig Wolfgang, Schulze Almut, Kroiß Matthias, Sbiera Silviu, Lapa Constantin, Mages Bianca, Strobel Sabrina, Hundt Jennifer Elisabeth, Bohnert Simone, Kircher Stefan, Janaki-Raman Sudha, Monoranu Camelia-Maria
Abstract excerpt
Targeting molecular alterations as an effective treatment for isocitrate dehydrogenase-wildtype glioblastoma (GBM) patients has not yet been established. Sterol-O-Acyl Transferase 1 (SOAT1), a key enzyme in the conversion of endoplasmic reticulum cholesterol to esters for storage in lipid droplets (LD), serves as a target for the orphan drug mitotane to treat adrenocortical carcinoma. Inhibition of SOAT1 also...
Topics
Join the communities discussing this publication.
